|
|
 |
|
Viewing report
|
|
|
|
Female Sexual Dysfunction Therapy Area Pipeline Report
Life Science Analytics, March 2009, Pages: 54
Life Science Analytics, Female Sexual Dysfunction Therapy Area Pipeline Report contains detailed information on the female sexual dysfunction drug pipeline. This report provides insight into the pipeline status of female sexual dysfunction drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
Customers who bought this item also bought
Womens Health Female Sexual Dysfunction
Female Sexual Dysfunction: Prescription Drug Pipeline Overview 2007
Stakeholder Opinions: Female Sexual Dysfunction - Results From Datamonitors 2005 Physician Survey
Major Milestones: Female Sexual Dysfunction
U.S. Sexual Dysfunction Medication Markets
Strategic Perspectives: Female Sexual Dysfunction - Are Physicians and Patients Ready For a Female Viagra?
Male and female sexual dysfunction: Blockbuster indication for multiple pharmacological targets
Female Sexual Pain Disorders: Evaluation and Management
The World Market For Sexual Disorders, 2005-2012: Traversing New Frontiers in Sexual Chemistry
Financial Markets Research: Palatin Technologies Bremelanotide - Competition and Regulatory Risk Cloud Potential
Lifestyle Drugs Market Outlook: Key Indications, Epidemiology, and Emergent Drugs
The Lifestyle Drugs Outlook To 2008: Unlocking New Value In Well-Being
|
|
|
|
